News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
681,900 Results
Type
Article (30803)
Company Profile (227)
Press Release (650865)
Multimedia
Podcasts (53)
Webinars (14)
Section
Business (222409)
Career Advice (1142)
Deals (34711)
Drug Delivery (109)
Drug Development (77243)
Employer Resources (93)
FDA (15326)
Job Trends (13740)
News (326737)
Policy (28582)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1831)
Accelerated approval (53)
ADA (36)
Adcomms (31)
Allergies (180)
Alliances (48573)
ALS (223)
Alzheimer's disease (1763)
Antibody-drug conjugate (ADC) (551)
Approvals (15974)
Artificial intelligence (719)
ASCO (302)
Autoimmune disease (349)
Automation (58)
Bankruptcy (342)
Best Places to Work (10550)
BIO (67)
Biologics (1)
BIOSECURE Act (18)
Biosimilars (220)
BioSpace Insights (72)
Biotechnology (159)
Bladder cancer (212)
Brain cancer (67)
Breast cancer (802)
Cancer (6151)
Cardiovascular disease (464)
Career advice (996)
Career pathing (36)
CAR-T (350)
CDC (36)
Celiac Disease (2)
Cell therapy (934)
Cervical cancer (54)
Clinical research (68270)
Collaboration (2219)
Commercialization (6)
Company closure (4)
Compensation (1563)
Complete response letters (78)
COVID-19 (2229)
CRISPR (125)
C-suite (1224)
Cystic fibrosis (155)
Data (8578)
Decentralized trials (2)
Denatured (6)
Depression (180)
Dermatology (101)
Diabetes (580)
Diagnostics (6770)
Digital health (59)
Diversity (6)
Diversity, equity & inclusion (31)
Drug discovery (363)
Drug pricing (110)
Drug shortages (13)
Duchenne muscular dystrophy (279)
Earnings (87987)
Editorial (40)
Employer branding (13)
Employer resources (96)
Events (113923)
Executive appointments (1077)
FDA (19365)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (21)
Frontotemporal dementia (33)
Funding (1752)
Gene editing (255)
Generative AI (63)
Gene therapy (696)
GLP-1 (903)
Government (3236)
Grass and pollen (6)
Guidances (412)
Healthcare (15928)
Hematology (165)
HIV (82)
Huntington's disease (60)
IgA nephropathy (112)
Immunology and inflammation (224)
Immuno-oncology (108)
Indications (227)
Infectious disease (2544)
Inflammatory bowel disease (218)
Inflation Reduction Act (8)
Influenza (131)
Intellectual property (327)
Interviews (199)
IPO (16112)
IRA (21)
Job creations (3527)
Job search strategy (837)
JPM (32)
Kidney cancer (22)
Labor market (87)
Layoffs (468)
Leadership (26)
Legal (7101)
Licensing (10)
Liver cancer (99)
Longevity (30)
Lung cancer (817)
Lymphoma (450)
Machine learning (61)
Management (34)
Manufacturing (1072)
Marketing (13)
MASH (195)
Medical affairs (1)
Medical device (12520)
Medtech (12722)
Mergers & acquisitions (19927)
Metabolic disorders (1417)
mRNA (216)
Multiple sclerosis (196)
NASH (20)
Neurodegenerative disease (422)
Neuropsychiatric disorders (95)
Neuroscience (3338)
Neurotech (1)
NextGen: Class of 2026 (5651)
Non-profit (2735)
Now hiring (35)
Obesity (589)
Opinion (200)
Ovarian cancer (244)
Pain (258)
Pancreatic cancer (337)
Parkinson's disease (378)
Partnered (30)
Patents (654)
Patient recruitment (807)
Peanut (58)
People (55999)
Pharmaceutical (45)
Pharmacy benefit managers (17)
Phase 1 (21583)
Phase 2 (30294)
Phase 3 (22037)
Pipeline (10576)
Policy (186)
Postmarket research (2194)
Preclinical (9094)
Press Release (68)
Prostate cancer (336)
Psychedelics (67)
Radiopharmaceuticals (329)
Rare diseases (1063)
Real estate (5333)
Recruiting (41)
Regulatory (23637)
Reports (42)
Research institute (1805)
Resumes & cover letters (157)
Rett syndrome (50)
RNA editing (22)
RSV (77)
Schizophrenia (167)
Series A (310)
Series B (232)
Service/supplier (5)
Sickle cell disease (114)
Special edition (20)
Spinal muscular atrophy (144)
Sponsored (34)
Startups (3604)
State (1)
Stomach cancer (18)
Supply chain (100)
Tariffs (52)
The Weekly (47)
Vaccines (963)
Venture capital (98)
Weight loss (356)
Women's health (124)
Worklife (13)
Date
Last 7 days (606)
Last 30 days (2220)
Last 365 days (28547)
2026 (18255)
2025 (28338)
2024 (33059)
2023 (37939)
2022 (48317)
2021 (51924)
2020 (49136)
2019 (40153)
2018 (30407)
2017 (29384)
2016 (28325)
2015 (34514)
2014 (28912)
2013 (24522)
2012 (26580)
2011 (26922)
2010 (25672)
Location
Africa (586)
Alabama (100)
Alaska (6)
Arizona (362)
Arkansas (14)
Asia (37148)
Australia (6061)
California (14357)
Canada (3975)
China (1462)
Colorado (588)
Connecticut (580)
Delaware (399)
Europe (77846)
Florida (2134)
Georgia (446)
Hawaii (4)
Idaho (61)
Illinois (1069)
India (103)
Indiana (623)
Iowa (20)
Japan (604)
Kansas (133)
Kentucky (49)
Louisiana (49)
Maine (77)
Maryland (1590)
Massachusetts (10246)
Michigan (349)
Minnesota (717)
Mississippi (5)
Missouri (126)
Montana (30)
Nebraska (22)
Nevada (150)
New Hampshire (78)
New Jersey (3648)
New Mexico (33)
New York (3666)
North Carolina (1667)
North Dakota (10)
Northern California (7301)
Ohio (387)
Oklahoma (20)
Oregon (31)
Pennsylvania (2752)
Puerto Rico (28)
Rhode Island (42)
South America (899)
South Carolina (85)
South Dakota (1)
Southern California (5763)
Tennessee (226)
Texas (2297)
United States (49543)
Utah (424)
Vermont (2)
Virginia (323)
Washington D.C. (57)
Washington State (1154)
West Virginia (4)
Wisconsin (129)
Wyoming (1)
681,900 Results for "base pair biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Neumora discards depression asset, lays off staffers after pair of late-stage flops
Neumora Therapeutics is laying off 35% of workers after its most advanced asset failed a pair of Phase 3 studies, sending the biotech’s stock spiraling early Monday.
June 15, 2026
·
2 min read
·
Gabrielle Masson
Funding
Epicrispr, Infinimmune snag combined $165M in VC cash
Epicrispr Biotechnologies is working on an epigenetic medicine for facioscapulohumeral muscular dystrophy, while Infinimmune will advance a pair of antibodies for atopic dermatitis.
August 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Renew Biotechnologies Unifies Wasatch BioLabs and Resonant Under One Brand to Advance Sequencing-Based Diagnostics
July 9, 2026
·
3 min read
Antibody-drug conjugate (ADC)
Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival
Treatment with the TROP2 ADC sac-TMT led to a 70% objective response rate and progression-free survival was “significantly improved” as compared to placebo—the second positive readout for the asset this week.
May 22, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy
July 14, 2026
·
8 min read
Press Releases
RoosterBio and Applied StemCell Partner to Advance Scalable iPSC-Based Bioprocess Solutions
July 8, 2026
·
5 min read
Press Releases
ELEPHAS BIOSCIENCES AND MITHRL PAIR REAL-TIME TUMOR PROFILING WITH AGENTIC AI TO UNLOCK NEW IMMUNOTHERAPY RESPONSE INSIGHTS
April 17, 2026
·
3 min read
Press Releases
Renew Biotechnologies Publishes Peer-Reviewed Research Advancing Cell-Type-Associated Biomarkers of Neurodegeneration
August 9, 2026
·
3 min read
Press Releases
Puma Biotechnology Reports Second Quarter 2026 Financial Results
August 7, 2026
·
17 min read
Press Releases
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment
Clinical Study on Track to Meet Primary Endpoints with Interim Data Demonstrating Blood-Based Assay Capable of Predicting Relapse Risk Through Analysis of Genomic Instability and Telomere Architecture
July 16, 2026
·
8 min read
1 of 68,190
Next
